NCT04099238View on ClinicalTrials.gov

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

CompletedOBSERVATIONAL
Enrollment

3,739

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

July 16, 2020

Study Completion Date

July 16, 2020

Conditions
Atrial Fibrillation
Interventions
DRUG

Oral anticoagulant

Oral anticoagulants may comprise vitamin K antagonists (VKA) and non-vitamin K antagonist oral antagonists (NOAC).

Trial Locations (1)

Unknown

Many facilities, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY